Yanjing Li

1.4k citations
13 papers · 1.1k indexed · 1 hit paper · h-index 11
Topics
Inflammasome and immune disorders (6 papers)Immune Cell Function and Interaction (3 papers)Cell death mechanisms and regulation (2 papers)
Partner nations
China

In The Last Decade

Yanjing Li

12 papers receiving 1.1k citations

Hit Papers

The caspase-3/GSDME signal pathway as a switch between ap...20202026202220242020100200300400

Peers

Yanjing Li
Comparison fields: 5 of 95
  • Molecular Biology 817
  • Immunology 247
  • Pulmonary and Respiratory Medicine 244
  • Cancer Research 180
  • Oncology 127
Replace Feng‐Yi Mai with:
Feng‐Yi Mai China
Lin An China
Jingyun Luan China
Chenglong Li China
Jing Kong China
Yidong Liu China
Hongyan Liu China
Huixiang Yang China
Lei Shen China
Songling Zhang China
Yanjing Li relative to Feng‐Yi Mai China Feng‐Yi Mai's profile →
Citations per field
00.5×
Feng‐Yi Mai · 1×
Citations per year

Countries citing papers authored by Yanjing Li

Since Specialization
Citations

This map shows the geographic impact of Yanjing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanjing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanjing Li more than expected).

Fields of papers citing papers by Yanjing Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanjing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanjing Li. The network helps show where Yanjing Li may publish in the future.

Co-authorship network of co-authors of Yanjing Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yanjing Li. A scholar is included among the top collaborators of Yanjing Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanjing Li. Yanjing Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 0
2 87
3 127
4 46
5 152
6 78
7
The caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancerbreakdown →
475
8 20
9 13
10 9
11 13
12 53
13 12

About Yanjing Li

Yanjing Li is a scholar working on Nephrology, Immunology and Molecular Biology, having authored 13 papers that have together received 1.1k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (6 papers), Immune Cell Function and Interaction (3 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Nephrology (111 citations), Cancer Research (180 citations) and Molecular Biology (817 citations). Yanjing Li has collaborated with scholars based in China. Frequent co-authors include Ling Qi, Mingxia Jiang, Lisha Li, Yuxian Bai, Yiming Wu, Dongfeng Song, Lisha Li, Junqing Gan, Kui Cao and Tongsen Zheng. Their work appears in journals such as Advanced Functional Materials, International Journal of Cancer and Cancer Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026